CS85991A3 - Polyfunctional pharmaceuticals - Google Patents
Polyfunctional pharmaceuticals Download PDFInfo
- Publication number
- CS85991A3 CS85991A3 CS91859A CS85991A CS85991A3 CS 85991 A3 CS85991 A3 CS 85991A3 CS 91859 A CS91859 A CS 91859A CS 85991 A CS85991 A CS 85991A CS 85991 A3 CS85991 A3 CS 85991A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- oxo
- dihydro
- purin
- ait
- solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/500,789 US5091432A (en) | 1990-03-28 | 1990-03-28 | 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
CS85991A3 true CS85991A3 (en) | 1992-02-19 |
Family
ID=23990941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS91859A CS85991A3 (en) | 1990-03-28 | 1991-03-28 | Polyfunctional pharmaceuticals |
Country Status (17)
Country | Link |
---|---|
US (1) | US5091432A (de) |
EP (1) | EP0522082B1 (de) |
JP (1) | JP3198335B2 (de) |
KR (1) | KR100194162B1 (de) |
AT (1) | ATE154880T1 (de) |
AU (1) | AU7678191A (de) |
CA (1) | CA2079342C (de) |
CS (1) | CS85991A3 (de) |
DE (1) | DE69126701T2 (de) |
DK (1) | DK0522082T3 (de) |
ES (1) | ES2104700T3 (de) |
GR (1) | GR3024904T3 (de) |
IE (1) | IE81123B1 (de) |
IL (1) | IL97638A (de) |
NZ (1) | NZ237574A (de) |
TW (1) | TW279865B (de) |
WO (1) | WO1991014434A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5447939A (en) * | 1994-07-25 | 1995-09-05 | Glasky; Alvin J. | Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
US6338963B1 (en) | 1994-07-25 | 2002-01-15 | Neotherapeutics, Inc. | Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
NZ291592A (en) | 1994-07-25 | 2001-03-30 | Michel P Rathbone | Use of carbon monoxide dependent guanylyl cyclase modulating purine derivative for treating neurological diseases |
US5801184A (en) * | 1994-07-25 | 1998-09-01 | Glasky; Alvin J. | Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
US20020022657A1 (en) * | 1998-02-11 | 2002-02-21 | Francine Gervais | Methods for modulating neuronal cell death |
WO1999057119A1 (en) * | 1998-05-04 | 1999-11-11 | Neotherapeutics, Inc. | Novel dopamine-like 9-substituted hypoxanthine and methods of use |
US6303617B1 (en) * | 1998-05-04 | 2001-10-16 | Neotherapeutics, Inc. | Serotonin-like 9-substituted hypoxanthine and methods of use |
US6297226B1 (en) | 1999-10-15 | 2001-10-02 | Neotherapeutics, Inc. | Synthesis and methods of use of 9-substituted guanine derivatives |
US6288069B1 (en) | 1999-11-16 | 2001-09-11 | Neotherapeutics, Inc. | Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
WO2001039723A2 (en) * | 1999-12-06 | 2001-06-07 | Euro-Celtique, S.A. | Triazospiro compounds having nociceptin receptor affinity |
US6407237B1 (en) * | 2001-02-21 | 2002-06-18 | Neotherapeutics, Inc. | Crystal forms of 9-substituted hypoxanthine derivatives |
US6849735B1 (en) * | 2000-06-23 | 2005-02-01 | Merck Eprova Ag | Methods of synthesis for 9-substituted hypoxanthine derivatives |
ES2385931T3 (es) | 2000-07-07 | 2012-08-03 | Spectrum Pharmaceuticals, Inc. | MÉTODOS PARA EL TRATAMIENTO DE NEUROPATíA PERIFÉRICA INDUCIDA POR UNA ENFERMEDAD Y AFECCIONES RELACIONADAS. |
WO2002004449A2 (en) * | 2000-07-07 | 2002-01-17 | Neotherapeutics, Inc. | Methods for treatment of conditions affected by activity of multidrug transporters |
US20020040032A1 (en) * | 2000-07-07 | 2002-04-04 | Glasky Michelle S. | Methods for stimulation of synthesis of synaptophysin in the central nervous system |
US20020040031A1 (en) * | 2000-07-07 | 2002-04-04 | Glasky Michelle S. | Methods for prevention of accumulation of amyloid beta peptide in the central nervous system |
WO2002058736A2 (en) * | 2000-12-12 | 2002-08-01 | Neotherapetics, Inc. | Use of 9-substituted purine analogues and other molecules to stimulate neurogenesis |
US6759427B2 (en) | 2001-04-20 | 2004-07-06 | Spectrum Pharmaceuticals, Inc. | Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
US20020156277A1 (en) * | 2001-04-20 | 2002-10-24 | Fick David B. | Synthesis and methods of use of purine analogues and derivatives |
US20030055249A1 (en) * | 2001-07-17 | 2003-03-20 | Fick David B. | Synthesis and methods of use of pyrimidine analogues and derivatives |
US6906190B2 (en) * | 2002-01-04 | 2005-06-14 | Ribapharm Inc. | Inhibitors for de novo-RNA polymerases and methods of identifying targets for same |
NZ546887A (en) | 2003-11-03 | 2009-04-30 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
US7473728B2 (en) * | 2004-12-16 | 2009-01-06 | The Goodyear Tire & Rubber Company | Dual phase rubber composition and tire with nanocomposite-containing sidewall thereof |
CA2900876A1 (en) | 2004-12-22 | 2006-08-17 | Bhi Limited Partnership | Methods and compositions for treating amyloid-related diseases |
ATE481094T1 (de) * | 2005-12-22 | 2010-10-15 | Kiacta Sarl | Behandlung von diabetischer nephropathie |
KR101443573B1 (ko) | 2006-10-12 | 2014-11-03 | 비에이치아이 리미티드 파트너쉽 | 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클 |
AU2007337806A1 (en) * | 2006-12-22 | 2008-07-03 | Bellus Health (International) Limited | Methods, compounds, and compositions for treating metabolic disorders and diabetes |
ES2916805T3 (es) * | 2012-11-21 | 2022-07-06 | Zoetis Services Llc | Síntesis de derivados de isoxazolina espirocíclicos |
CN115521306B (zh) * | 2022-09-26 | 2024-03-26 | 贵州大学 | 一种1,2,3,4-四氢-β-咔啉衍生物及其制备方法和应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3321369A (en) * | 1965-05-26 | 1967-05-23 | Abbott Lab | Method of enhancing learning rate and retention level in warm blooded animals |
US3484521A (en) * | 1966-06-23 | 1969-12-16 | Int Chem & Nuclear Corp | Enhancement of memory processes in mammals with basic addition salts of ribonucleic acid |
US4221910A (en) * | 1978-09-15 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | 9-(Hydroxy alkyl)purines |
US4221909A (en) * | 1978-09-15 | 1980-09-09 | Sloan-Kettering Institute For Cancer Research | P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines |
US4221794A (en) * | 1979-06-21 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | Method of imparting immunomodulating and antiviral activity |
IL64501A (en) * | 1980-12-22 | 1985-07-31 | Astra Laekemedel Ab | 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use |
US4728605A (en) * | 1984-07-31 | 1988-03-01 | Fudenberg Herman H | Methods for recognizing and diagnosing subsets of Alzheimer's disease associated with immune system dysfunction, and for the in vitro testing of possible therapeutic agents for treatment of same |
US4952693A (en) * | 1984-10-12 | 1990-08-28 | Warner-Lambert Company | Oxazolo-pyrimidine derivatives |
-
1990
- 1990-03-28 US US07/500,789 patent/US5091432A/en not_active Expired - Lifetime
-
1991
- 1991-03-21 IL IL9763891A patent/IL97638A/en not_active IP Right Cessation
- 1991-03-26 WO PCT/US1991/002066 patent/WO1991014434A1/en active IP Right Grant
- 1991-03-26 CA CA002079342A patent/CA2079342C/en not_active Expired - Fee Related
- 1991-03-26 ES ES91908058T patent/ES2104700T3/es not_active Expired - Lifetime
- 1991-03-26 AT AT91908058T patent/ATE154880T1/de not_active IP Right Cessation
- 1991-03-26 JP JP50760291A patent/JP3198335B2/ja not_active Expired - Fee Related
- 1991-03-26 DE DE69126701T patent/DE69126701T2/de not_active Expired - Fee Related
- 1991-03-26 DK DK91908058.0T patent/DK0522082T3/da active
- 1991-03-26 KR KR1019920702359A patent/KR100194162B1/ko not_active IP Right Cessation
- 1991-03-26 EP EP91908058A patent/EP0522082B1/de not_active Expired - Lifetime
- 1991-03-26 IE IE99491A patent/IE81123B1/en not_active IP Right Cessation
- 1991-03-26 AU AU76781/91A patent/AU7678191A/en not_active Abandoned
- 1991-03-26 NZ NZ237574A patent/NZ237574A/xx unknown
- 1991-03-27 TW TW080102367A patent/TW279865B/zh active
- 1991-03-28 CS CS91859A patent/CS85991A3/cs unknown
-
1997
- 1997-10-01 GR GR970402551T patent/GR3024904T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU7678191A (en) | 1991-10-21 |
DE69126701D1 (de) | 1997-08-07 |
JPH05508390A (ja) | 1993-11-25 |
ATE154880T1 (de) | 1997-07-15 |
IL97638A0 (en) | 1992-06-21 |
DK0522082T3 (da) | 1997-07-21 |
WO1991014434A1 (en) | 1991-10-03 |
DE69126701T2 (de) | 1997-12-04 |
EP0522082A4 (en) | 1993-06-09 |
ES2104700T3 (es) | 1997-10-16 |
CA2079342C (en) | 2001-10-23 |
IE910994A1 (en) | 1991-10-09 |
EP0522082B1 (de) | 1997-07-02 |
GR3024904T3 (en) | 1998-01-30 |
IL97638A (en) | 1999-03-12 |
CA2079342A1 (en) | 1991-09-29 |
TW279865B (de) | 1996-07-01 |
NZ237574A (en) | 1993-09-27 |
US5091432A (en) | 1992-02-25 |
EP0522082A1 (de) | 1993-01-13 |
KR100194162B1 (ko) | 1999-06-15 |
JP3198335B2 (ja) | 2001-08-13 |
IE81123B1 (en) | 2000-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS85991A3 (en) | Polyfunctional pharmaceuticals | |
DE60315615T2 (de) | Tricyclische verbindungen basierend auf thiophen und arzneimittel, die diese umfassen | |
EP1768985B1 (de) | Pyrimdobenzimidazolderivate und verwendung damit als agonisten oder antagonisten von melanocortinrezeptoren | |
KR100667645B1 (ko) | 환상 아민 ccr3 길항제 | |
WO2004032874A2 (en) | AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE | |
AU2006216713A1 (en) | PGD2 receptor antagonists for the treatment of inflammatory diseases | |
KR20020041456A (ko) | 9-치환 구아닌 유도체의 합성 및 사용 방법 | |
US20130338372A1 (en) | Substituted Imidazoline Compounds | |
LT3671B (en) | Substituted 1-(1h-imidazol-4-il)alkylbenzamides | |
JP2003503482A (ja) | 環化アミノ酸誘導体 | |
SK282766B6 (sk) | Diazepinoindoly ako inhibítory fosfodiesterázy IV, ich použitie ako liečiv a farmaceutické kompozície s ich obsahom | |
JP2519734B2 (ja) | 新規置換ピリド〔2,3−b〕〔1,4〕ベンゾジアゼピン−6−オン,その製法及びその化合物を含む医薬 | |
JPH05509314A (ja) | 治療薬 | |
RU2379305C2 (ru) | Соединение тиоморфолина и способ его получения | |
JP2003503476A (ja) | 環化アミド誘導体 | |
WO2009064274A1 (en) | Enantiomerically enriched imidazoazepinone compounds | |
US6583138B1 (en) | Heterocyclic-ring condensed benzothiazine compound | |
US5114944A (en) | 2-phenylpyrazolo[1,5-a]pyrimidine-3-acetic acid derivatives exhibiting therapeutic effects | |
US5057534A (en) | 3-amino-5-arylpyrazole-4-acetic acid derivatives exhibiting therapeutic effects | |
CN116535390A (zh) | pH敏感型4-酰胺哌啶类衍生物、药物组合物及其制备方法和应用 | |
ITMI931897A1 (it) | Derivati 1,3,4- benzotriazepin-5(4h)-one e procedimento per la loro preparazione | |
JPH0395166A (ja) | イソキサゾロン誘導体含有脳機能改善剤 | |
US20220332750A1 (en) | Adenosine compound, its pharmaceutically acceptable salt or its stereoisomer and use thereof | |
NO318757B1 (no) | 2-{4-[4-(4,5-diklor-2-metylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluorpyrimidin, fremstilling og terapeutisk anvendelse | |
JPH01265070A (ja) | カルバモイル−2−ピロリジノン化合物 |